{
  "slug": "schrdinger",
  "name": "schrdinger",
  "description": "Schrödinger provides a physics-based computational platform that accelerates drug discovery and materials design. It offers a comprehensive suite of software solutions for molecular modeling, simulation, and data analysis to pharmaceutical, biotechnology, and materials science companies and academic institutions.",
  "url": "https://optimly.ai/brand/schrdinger",
  "websiteUrl": "https://schrdinger.com/",
  "logoUrl": "https://logo.clearbit.com/schrdinger.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Life Sciences Software",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:44.617Z",
  "verifiedVitals": {
    "website": "https://schrdinger.com",
    "founded": "1990",
    "headquarters": "New York, NY",
    "pricing_model": "Primarily enterprise software licenses and subscriptions, often tailored based on customer size and usage requirements.",
    "core_products": "Computational chemistry software platform for molecular modeling, simulation, and data analysis; includes tools for ligand design, protein modeling, and materials informatics.",
    "key_differentiator": "A unique physics-based computational platform combined with machine learning, offering high accuracy and integration across the entire drug discovery and materials design pipeline, from target identification to lead optimization.",
    "target_markets": "Pharmaceutical companies, biotechnology firms, materials science organizations, academic research institutions.",
    "employee_count": "Approximately 600-700 employees (variable)",
    "funding_stage": "Publicly Traded (NASDAQ: SDGR)",
    "subcategory": "Drug Discovery & Materials Science Platform"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional Wet-Lab Chemistry and Biology: Reliance on empirical experimentation, high-throughput screening, and manual synthesis and testing in laboratories, which is time-consuming and costly compar",
      "Contract Research Organizations (CROs): Engaging external CROs that specialize in drug discovery services, which may use their own proprietary or third-party computational tools, but for a service fee",
      "Maintain current R&D processes: Continuing with existing internal computational tools and experimental methods without adopting advanced physics-based or AI-driven platforms, potentially leading to sl"
    ],
    "solutionIntents": [
      "Schrödinger drug discovery software",
      "Schrödinger computational chemistry",
      "Schrödinger materials science platform",
      "What does Schrödinger Inc do?",
      "Schrödinger stock price",
      "Molecular modeling software Schrödinger",
      "Open-source Computational Chemistry Tools: Utilizing various open-source software packages and libraries for molecular modeling and simulation (e.g., GROMACS, Amber, RDKit, PyMOL), which offer flexibi"
    ],
    "evaluationIntents": [
      "Schrödinger vs Certara"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1786528415441
}